Talk:CREATES Act

	United States portal This article is within the scope of WikiProject United States, a collaborative effort to improve the coverage of topics relating to the United States of America on Wikipedia. If you would like to participate, please visit the project page, where you can join the ongoing discussions. Template Usage Articles Requested! Become a Member Project Talk Alerts United StatesWikipedia:WikiProject United StatesTemplate:WikiProject United StatesUnited States articles
Low	This article has been rated as Low-importance on the project's importance scale.

Law Low‑importance

	Law portal This article is within the scope of WikiProject Law, an attempt at providing a comprehensive, standardised, pan-jurisdictional and up-to-date resource for the legal field and the subjects encompassed by it.LawWikipedia:WikiProject LawTemplate:WikiProject Lawlaw articles
Low	This article has been rated as Low-importance on the project's importance scale.

Medicine Low‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Low	This article has been rated as Low-importance on the project's importance scale.

Economics Low‑importance

	Business and economics portal This article is within the scope of WikiProject Economics, a collaborative effort to improve the coverage of Economics on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.EconomicsWikipedia:WikiProject EconomicsTemplate:WikiProject EconomicsEconomics articles
Low	This article has been rated as Low-importance on the project's importance scale.

Note

In response to the note at my talk page here... I am not a big fan of articles about bills (which may never become law). The refs are also not great - there are two pieces by a Forbes contributor (they don't count toward N), some opinion pieces (Bloomberg and WaPo), two refs from the Axios blog, and the bill itself. Oh and the intercept which is also bloggy. So.. hm.

How would you feel about adding a short section on this to Prescription drug prices in the United States and redirecting there? Jytdog (talk) 22:26, 12 February 2018 (UTC)[reply]

@Jytdog: Yeah those seem reasonable points. I think highlighting the REMS process for review as well as sampling and the litigation regarding this for pharmaceutical companies embedded to block generic production seem the main "market place" factors driving the bill. Overall these are ingrained in the current system and notable in themselves in any article relating to the topic - Prescription drug prices in the United States as you mentioned. I think it also relates pretty relevantly to February 2018 budget package and could be included as a snippet in there. Overall I think there's a good "variety" of sources available on this topic that I found when searching, although a good amount could be considered "opinion" / "spin" due to it being a proposed bill that has yet to hit the floor. Shaded0 (talk) 14:10, 13 February 2018 (UTC)[reply]